PUBLICATION

ELAVL1a is an immunocompetent protein that protects zebrafish embryos from bacterial infection

Authors
Ni, S., Zhou, Y., Song, L., Chen, Y., Wang, X., Du, X., Zhang, S.
ID
ZDB-PUB-210228-2
Date
2021
Source
Communications biology   4: 251 (Journal)
Registered Authors
Keywords
none
MeSH Terms
  • Animals
  • Lipopolysaccharides/metabolism
  • Zebrafish Proteins/genetics
  • Zebrafish Proteins/metabolism*
  • ELAV Proteins/genetics
  • ELAV Proteins/metabolism*
  • Zebrafish/embryology
  • Zebrafish/genetics
  • Zebrafish/metabolism*
  • Zebrafish/microbiology
  • Protein Binding
  • Gene Expression Regulation, Developmental
  • Lipid A/metabolism
  • Phylogeny
  • Gram-Negative Bacteria/immunology
  • Gram-Negative Bacteria/pathogenicity*
  • Teichoic Acids/metabolism
  • Mutation
  • Gram-Positive Bacterial Infections/immunology
  • Gram-Positive Bacterial Infections/metabolism
  • Gram-Positive Bacterial Infections/microbiology
  • Gram-Positive Bacterial Infections/prevention & control*
  • Gram-Negative Bacterial Infections/immunology
  • Gram-Negative Bacterial Infections/metabolism
  • Gram-Negative Bacterial Infections/microbiology
  • Gram-Negative Bacterial Infections/prevention & control*
PubMed
33637956 Full text @ Commun Biol
Abstract
Previous studies have shown that ELAVL1 plays multiple roles, but its overall biological function remains ill-defined. Here we clearly demonstrated that zebrafish ELAVL1a was a lipoteichoic acid (LTA)- and LPS-binding protein abundantly stored in the eggs/embryos of zebrafish. ELAVL1a acted not only as a pattern recognition receptor, capable of identifying LTA and LPS, as well as bacteria, but also as an effector molecule, capable of inhibiting the growth of Gram-positive and -negative bacteria. Furthermore, we reveal that the C-terminal 62 residues of ELAVL1a positioned at 181-242 were indispensable for ELAVL1a antibacterial activity. Additionally, site-directed mutagenesis revealed that the hydrophobic residues Val192/Ile193, as well as the positively charged residues Arg203/Arg204, were the functional determinants contributing to the antimicrobial activity of rELAVL1a. Importantly, microinjection of rELAVL1a into embryos markedly promoted their resistance against pathogenic Aeromonas hydrophila challenge, and this pathogen-resistant activity was considerably reduced by co-injection of anti-ELAVL1a antibody or by knockdown with morpholino for elavl1a. Collectively, our results indicate that ELAVL1a is a maternal immune factor that can protect zebrafish embryos from bacterial infection. This work also provides another angle for understanding the biological roles of ELAVL1a.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping